Status Epileptikus Tedavisinde Ketojenik Diyet Kullanımı

Authors

Gürkan Gürbüz

Synopsis

The ketogenic diet (KD) is an effective treatment method composed of high fat, adequate protein, and restricted carbohydrates, widely used since the 1920s to control drug-resistant seizures. Based on the principle of meeting primary cerebral energy requirements from ketone bodies, this diet exhibits antiepileptic, anti-inflammatory, and neuroprotective effects. In cases of super-refractory status epilepticus (SRSE) that fail to respond to standard antiepileptic treatments and intravenous anesthetics, it provides high clinical success, particularly in febrile infection-related epilepsy syndrome (FIRES). Before initiating KD therapy, metabolic screenings, biochemical tests, and organ ultrasonographies must be performed, and absolute contraindications such as beta-oxidation defects and pyruvate carboxylase deficiency, as well as hemodynamic instability, must be ruled out. Concomitant use with propofol should be avoided during treatment due to the risk of propofol infusion syndrome. In practice, all dextrose-containing fluids are discontinued, and a ketogenic formula prepared generally at a 4:1 ratio (3:1 in patients under 18 months) is administered via continuous infusion through a nasogastric tube. Patients are monitored in the intensive care unit with EEG monitoring, blood glucose, and capillary ketone levels (target >4 mmol/L). Although minor gastroenterological and metabolic side effects such as vomiting, reflux, hypoglycemia, and hypertriglyceridemia may occur, life-threatening complications are rare in the acute phase. Because contraindications are limited, initiating KD without delay in patients diagnosed with SRSE is of vital importance in reducing morbidity and mortality.

References

Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Bulletin 1921;2:307-8.

Koh S, Dupuis N, Auvin S. Ketogenic diet and Neuroinflammation. Epilepsy Res 2020;167:106454.

Castro K, Faccioli LS, Baronio D, Gottfried C, Perry I. S, dos Santos Riesgo R. Effect of a ketogenic diet on autism spectrum disorder: A systematic review. Research in Autism Spectrum Disorders 2015; 20: 31-8.

Maurer GD, Brucker DP, Bähr O, Harter PN, Hattingen E, Walenta S et. al. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC cancer 2011;11:1-17.

Samanta D, Garrity L, Arya R. Refractory and super-refractory status epilepticus. Indian pediatrics 2020; 57.3: 239-53.

Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina BA, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018; 3:175–92.

Unalp A. Çocukluk çağı epilepsilerinde ketojenik diyet uygulamaları. Izmir Dr. Behçet Uz Çocuk Hast. Dergisi 2017;7:169-77.

Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D et al. Recognition and managementof fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999;22:488–502.

Baumeister FA, Oberhoffer R, Liebhaber GM, Kunkel J, Eberhardt J, Holthausen H, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004; 35: 250-2.

Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus. Seizure 2019;68:62-71.

Tully I, Draper ES, Lamming CR, Mattison D, Thomas C, Martland T, et al. Admissions to paediatric intensive care units (PICU) with refractory convulsive status epilepticus (RCSE): a two-year multi-centre study. Seizure 2015;29:153-161.

Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia 2018;59:745-52.

Villeneuve N, Pinton F, Bahi-Buisson N, Dulac O, Chiron C, Nabbout R. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol 2009;51:276–81.

Nabbout R, Mazzuca M, Hubert P, Peudennier S, Allaire C, Flurin V, Aberastury M, Silva W, Dulac O. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033-7.

Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic Diet Treatment for Pediatric Super-Refractory Status Epilepticus. Seizure. 2016;41:62-5.

Peng P, Peng J, Yin F, Deng X, Chen C, He F, Wang X, Guang S, Mao L. Ketogenic Diet as a Treatment for Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome. Front Neurol. 2019;26;423.

Gürbüz G, Kumru B, Özsevik S, Bilgiç AE, Ünalp A. The Efficacy, Safety and Side-Effect Profile of the Ketogenic Diet in the Treatment of Pediatric Super-Refractory Status Epilepticus. J Nutri Med Diet Care 2019;5:041.

Farias-Moeller R, Bartolini L, Pasupuleti A, Brittany Cines RD, Kao A, Carpenter JL. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care. 2017;26:267–72.

Villeneuve N, Pinton F, Bahi-Buisson N, Dulac O, Chiron C, Nabbout R. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol. 2009;51:276-81.

Vaccarezza M, Silva W, Maxit C, Agosta G. Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics (Spanish). Rev Neurol. 2012;55:20-5.

O'Connor SE, Ream MA, Richardson C, Mikati MA, Trescher WH, Byler DL et al. The ketogenic diet for the treatment of pediatric status epilepticus. Pediatr Neurol. 2014;50:101-103. Erratum in: Pediatr Neurol. 2014;51(2):286. Ream, Margie A [added]; Mikati, Mohamad A [added]. PMID: 24287234.

Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS, CHEESE Study Group. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol. 2015;52(4):442-45.

Strzelczyk A, Reif PS, Bauer S, Belke M, Oertel WH, Knake S, Rosenow F. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure-European Journal of Epilepsy, 2013; 22: 581-83.

Published

September 30, 2021

License

License